Paul Tudor Jones Insmed Inc Transaction History

Tudor Investment Corp Et Al

$29 Billion
Q1 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Insmed Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 8,000 shares of INSM stock, worth $530,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,000

Previous 10,200 21.57%

Holding current value

$530,880

Previous $704,000 13.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $736,932 - $939,112	11,886 New	11,886 $867,000
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $55,575 - $75,319	-2,373 Reduced 9.34%	23,044 $714,000
Q3 2023 Nov 15, 2023	SELL	$19.86 - $26.93 $271,307 - $367,890	-13,661 Reduced 34.96%	25,417 $641,000
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $496,159 - $636,798	-30,180 Reduced 43.58%	39,078 $824,000
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $60,535 - $80,900	-3,723 Reduced 5.1%	69,258 $1.18 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $183,214 - $249,788	10,790 Added 17.35%	72,981 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $3,278 - $4,428	157 Added 0.25%	62,191 $1.34 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $284,454 - $428,431	16,664 Added 36.73%	62,034 $1.22 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $142,919 - $196,881	6,999 Added 18.24%	45,370 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $993,425 - $1.28 Million	38,371 New	38,371 $1.05 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $264,680 - $659,857	-19,419 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $32,659 - $50,609	2,026 Added 11.65%	19,419 $464,000
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $512,223 - $852,493	-33,068 Reduced 65.53%	17,393 $307,000
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $722,936 - $1.01 Million	31,432 Added 165.18%	50,461 $1.29 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $264,693 - $592,753	19,029 New	19,029 $553,000
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $301,320 - $447,761	-15,066 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $131,094 - $199,391	6,044 Added 66.99%	15,066 $339,000
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $704,280 - $846,841	-26,647 Reduced 74.71%	9,022 $281,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $414,117 - $1.11 Million	35,669	35,669 $1.11 Million

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.99B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account